PharmaCielo Ltd.
PCLOF
$0.03
-$0.01-17.21%
OTC PK
| 09/30/2024 | 09/30/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.99% | -2.99% | -4.84% | -4.84% | 61.80% |
| Total Depreciation and Amortization | -155.68% | -108.20% | -46.76% | 261.29% | -73.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.70% | 13.65% | 145.91% | 112.72% | -75.46% |
| Change in Net Operating Assets | 97.11% | 97.11% | -123.81% | -123.81% | 9.69% |
| Cash from Operations | 8.37% | 8.37% | -41.79% | -41.79% | 71.77% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | -- | -30.84% |
| Cash from Investing | -- | -- | -100.00% | -100.00% | -24.13% |
| Total Debt Issued | -100.00% | -100.00% | 112.70% | 172.38% | -82.64% |
| Total Debt Repaid | 82.33% | 82.33% | -528.66% | -528.66% | 81.98% |
| Issuance of Common Stock | 42.82% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -200.00% | -- | -- |
| Cash from Financing | 14.52% | 14.52% | -5.19% | -5.19% | -66.42% |
| Foreign Exchange rate Adjustments | 84.85% | 84.85% | -222.22% | -222.22% | -68.60% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 89.55% | 89.55% | -217.82% | -217.82% | 205.73% |